GI
PRCT icon

GAMMA Investing’s Procept Biorobotics PRCT Stock Holding History

GAMMA Investing’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64K Sell
294
-40
-12% -$1K ﹤0.01% 3367
2026
Q1 		$8.35K Buy
334
+99
+42% +$2.79K ﹤0.01% 3164
2025
Q4 		$7.39K Buy
235
+132
+128% +$4.38K ﹤0.01% 3114
2025
Q3 		$3.68K Sell
103
-64
-38% -$2.92K ﹤0.01% 3289
2025
Q2 		$9.62K Buy
167
+57
+52% +$3.22K ﹤0.01% 2821
2025
Q1 		$6.41K Buy
110
+20
+22% +$1.37K ﹤0.01% 2969
2024
Q4 		$7.25K Buy
90
+50
+125% +$4.27K ﹤0.01% 2755
2024
Q3 		$3.21K Buy
40
+22
+122% +$1.56K ﹤0.01% 2913
2024
Q2 		$1.1K Buy
18
+12
+200% +$714 ﹤0.01% 3030
2024
Q1 		$297 Hold
6
– – ﹤0.01% 3181
2023
Q4 		$278 Buy
+6
New +$204 ﹤0.01% 3089

Other funds holding PRCT

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
KCM
KRS Capital Management Bloomfield, Michigan $215M AUM 69.3% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Enclave Advisors Austin, Texas $790M AUM 21.99% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

GAMMA Investing's PRCT Position: Q2 2026 in Review

GAMMA Investing reduced its Procept Biorobotics (PRCT) stake by 12% in Q2 2026, selling an estimated $1K and leaving 294 shares worth $6.64K. The position accounts for ﹤0.01% of the portfolio, ranked #3367.

GAMMA Investing first reported a position in PRCT in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.62K in Q2 2025. 20 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • GAMMA Investing held 294 shares of Procept Biorobotics worth $6.64K as of Q2 2026.
  • GAMMA Investing sold 40 Procept Biorobotics shares in Q2 2026, an estimated $1K.
  • Procept Biorobotics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3367 holding.
  • GAMMA Investing first reported a position in Procept Biorobotics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Procept Biorobotics position peaked at $9.62K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.